Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
13.17
-0.02 (-0.15%)
Jun 12, 2026, 4:00 PM EDT - Market closed
Cross Country Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,002 | 1,054 | 1,344 | 2,020 | 2,803 | 1,677 | |
Revenue Growth (YoY) | -20.37% | -21.56% | -33.46% | -27.95% | 67.20% | 100.46% |
Cost of Revenue | 799.44 | 840.72 | 1,070 | 1,569 | 2,179 | 1,302 |
Gross Profit | 202.5 | 213.57 | 274.25 | 450.41 | 624.46 | 375 |
Selling, General & Admin | 194.01 | 200.68 | 233.38 | 300.33 | 324.21 | 216.36 |
Depreciation & Amortization Expenses | 15.69 | 16.79 | 18.2 | 18.35 | 12.58 | 9.85 |
Other Operating Expenses | 80.4 | 80.51 | 39.54 | 19.02 | 17.79 | 9.48 |
Total Operating Expenses | 290.1 | 297.99 | 291.12 | 337.7 | 354.58 | 235.7 |
Operating Income | -87.59 | -84.41 | -16.87 | 112.71 | 269.88 | 139.3 |
Interest Income | 3.42 | 3.13 | 2.05 | 0.08 | 0.01 | - |
Interest Expense | -2.24 | -2.22 | -2.19 | -8.09 | -14.39 | -6.87 |
Other Non-Operating Income (Expense) | -0.07 | 0.01 | -0.61 | -1.64 | -5.05 | -0.77 |
Total Non-Operating Income (Expense) | 1.12 | 0.92 | -0.74 | -9.65 | -19.44 | -7.64 |
Pretax Income | -86.35 | -83.51 | -16.4 | 102.89 | 253.1 | 133.21 |
Provision for Income Taxes | 12.28 | 11.34 | -1.84 | 30.26 | 67.12 | 1.21 |
Net Income | -98.63 | -94.85 | -14.56 | 72.63 | 185.98 | 132 |
Net Income to Common | -98.63 | -94.85 | -14.56 | 72.63 | 185.98 | 132 |
Net Income Growth | - | - | - | -60.95% | 40.89% | - |
Shares Outstanding (Basic) | 32 | 32 | 33 | 35 | 37 | 37 |
Shares Outstanding (Diluted) | 32 | 32 | 33 | 35 | 38 | 37 |
Shares Change (YoY) | -2.14% | -2.91% | -5.91% | -5.49% | 0.39% | 3.61% |
EPS (Basic) | -3.05 | -2.93 | -0.44 | 2.07 | 5.02 | 3.60 |
EPS (Diluted) | -3.05 | -2.93 | -0.44 | 2.05 | 4.95 | 3.53 |
EPS Growth | - | - | - | -58.59% | 40.23% | - |
Free Cash Flow | 39.6 | 40.09 | 111.4 | 234.52 | 125.26 | -92.79 |
Free Cash Flow Growth | -1.21% | -64.01% | -52.50% | 87.22% | - | - |
Free Cash Flow Per Share | 1.23 | 1.24 | 3.34 | 6.61 | 3.34 | -2.48 |
Gross Margin | 20.21% | 20.26% | 20.41% | 22.30% | 22.28% | 22.37% |
Operating Margin | -8.74% | -8.01% | -1.25% | 5.58% | 9.63% | 8.31% |
Profit Margin | -9.84% | -9.00% | -1.08% | 3.60% | 6.63% | 7.87% |
FCF Margin | 3.95% | 3.80% | 8.29% | 11.61% | 4.47% | -5.53% |
EBITDA | -71.9 | -67.62 | 1.34 | 131.06 | 282.46 | 149.16 |
EBITDA Margin | -7.18% | -6.41% | 0.10% | 6.49% | 10.08% | 8.90% |
EBIT | -87.59 | -84.41 | -16.87 | 112.71 | 269.88 | 139.3 |
EBIT Margin | -8.74% | -8.01% | -1.25% | 5.58% | 9.63% | 8.31% |
Effective Tax Rate | -14.23% | -13.58% | 11.23% | 29.41% | 26.52% | 0.91% |